Your browser doesn't support javascript.
loading
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.
Guidon, Amanda C; Burton, Leeann B; Chwalisz, Bart K; Hillis, James; Schaller, Teilo H; Amato, Anthony A; Betof Warner, Allison; Brastianos, Priscilla K; Cho, Tracey A; Clardy, Stacey L; Cohen, Justine V; Dietrich, Jorg; Dougan, Michael; Doughty, Christopher T; Dubey, Divyanshu; Gelfand, Jeffrey M; Guptill, Jeffrey T; Johnson, Douglas B; Juel, Vern C; Kadish, Robert; Kolb, Noah; LeBoeuf, Nicole R; Linnoila, Jenny; Mammen, Andrew L; Martinez-Lage, Maria; Mooradian, Meghan J; Naidoo, Jarushka; Neilan, Tomas G; Reardon, David A; Rubin, Krista M; Santomasso, Bianca D; Sullivan, Ryan J; Wang, Nancy; Woodman, Karin; Zubiri, Leyre; Louv, William C; Reynolds, Kerry L.
Afiliação
  • Guidon AC; Harvard Medical School, Boston, Massachusetts, USA AGUIDON@PARTNERS.ORG kreynolds7@partners.org.
  • Burton LB; Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Chwalisz BK; Harvard Medical School, Boston, Massachusetts, USA.
  • Hillis J; Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Schaller TH; Harvard Medical School, Boston, Massachusetts, USA.
  • Amato AA; Division of Neuroimmunology and Neuroinfectious Disease, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Betof Warner A; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
  • Brastianos PK; Harvard Medical School, Boston, Massachusetts, USA.
  • Cho TA; Division of Neuroimmunology and Neuroinfectious Disease, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Clardy SL; Project Data Sphere, Cary, North Carolina, USA.
  • Cohen JV; Harvard Medical School, Boston, Massachusetts, USA.
  • Dietrich J; Division of Neuromuscular Medicine, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
  • Dougan M; Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Doughty CT; Harvard Medical School, Boston, Massachusetts, USA.
  • Dubey D; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Gelfand JM; Department of Neurology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
  • Guptill JT; Department of Neurology, University of Utah, Salt Lake CIty, UT, USA.
  • Johnson DB; Division of Oncology, Department of Medicine, University of Pennsylvania, PA, USA.
  • Juel VC; Harvard Medical School, Boston, Massachusetts, USA.
  • Kadish R; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Kolb N; Harvard Medical School, Boston, Massachusetts, USA.
  • LeBoeuf NR; Department of Medicine, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Linnoila J; Harvard Medical School, Boston, Massachusetts, USA.
  • Mammen AL; Division of Neuromuscular Medicine, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
  • Martinez-Lage M; Departments of Neurology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Mooradian MJ; Department of Neurology, UCSF, San Francisco, California, USA.
  • Naidoo J; Duke Clinical Research Institute, Duke University, Durham, NC, USA.
  • Neilan TG; Division of Neuromuscular Medicine, Duke University, Durham, NC, USA.
  • Reardon DA; Division of Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Rubin KM; Division of Neuromuscular Medicine, Duke University, Durham, NC, USA.
  • Santomasso BD; Department of Neurology, University of Utah, Salt Lake CIty, UT, USA.
  • Sullivan RJ; Division of Neuromuscular Medicine, Department of Neurology, University of Vermont, Burlington, VT, USA.
  • Wang N; Harvard Medical School, Boston, Massachusetts, USA.
  • Woodman K; Department of Dermatology, Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Zubiri L; Harvard Medical School, Boston, Massachusetts, USA.
  • Louv WC; Division of Neuroimmunology and Neuroinfectious Disease, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Reynolds KL; Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
J Immunother Cancer ; 9(7)2021 07.
Article em En | MEDLINE | ID: mdl-34281989
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Inibidores de Checkpoint Imunológico / Imunoterapia / Doenças do Sistema Nervoso Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Inibidores de Checkpoint Imunológico / Imunoterapia / Doenças do Sistema Nervoso Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article